IBER
Ibere Pharmaceuticals
IBER
IBER
Delisted
IBER was delisted on the 1st of March, 2023.
47 hedge funds and large institutions have $126M invested in Ibere Pharmaceuticals in 2022 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 7 increasing their positions, 5 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
Holders
47
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$3.28M | |
| 2 | +$2.52M | |
| 3 | +$2.46M | |
| 4 |
GCL
Glazer Capital LLC
New York
|
+$2.46M |
| 5 |
HIM
HGC Investment Management
Toronto,
Ontario, Canada
|
+$495K |
Top Sellers
| 1 | -$2.44M | |
| 2 | -$2.26M | |
| 3 | -$1.26M | |
| 4 |
Janus Henderson Group
London,
United Kingdom
|
-$534K |
| 5 |
PI
PEAK6 Investments
Chicago,
Illinois
|
-$496K |